2' min read
2' min read
The researchers and biotech companies have a new space available in Trentino, and specifically in Pergine Valsugana, with 325 square metres of laboratories, 208 square metres for office use, and over 500 square metres for logistics.
This is the new Life Sciences Hub of Trentino Sviluppo, desired by the Autonomous Province of Trento to bring together skills and technologies in a single space, and to enhance "a fundamental sector for the sustainable growth of the territory, that of the life sciences", as explained by the Councillor for Economic Development, Labour, University and Research Achille Spinelli during the inauguration.
"A system choice aimed at creating virtuous collaborations and ensuring that this initial public investment stimulates private initiative and allows start-ups in the area to be competitive at an Italian and international level.
The Hub's laboratories are equipped with state-of-the-art machinery worth a total of around 280,000, including cell-counters, nucleofectors, chemical and biological hoods, shakers, autoclaves and refrigerators for cell preservation. There is already a first one established, the start-up Alia Therapeutics founded by researchers from the Department of Cell, Computational and Integrated Biology (CIBIO) of the University of Trento.
It is the first Italian company specialising in genome editing with CRISPR for the treatment of rare diseases, a technique that allows the targeted correction of DNA sequences to eliminate or replace harmful sequences, as CEO Letizia Goretti explained.
